MINDERA HEALTH
Live / Applied — Suspended — suspension check completed, case still suspended (as of 31 Jan 2026)
What this means for you
Not registered yet, but its 05 Jan 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97742599
- Mark type
- Design + words
- Filed
- 05 Jan 2023
- Attorney of record
- Johnny F. Manriquez
Goods and services
- Class 042 — Scientific and technological services: Scientific and medical research, namely, analysis of cells, proteins and nucleic acids; Software as a service (SaaS) services and platform as a service (PaaS) featuring computer software platforms using machine-learning algorithms for collecting, storing, analyzing, sharing, reporting, and processing data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostic research, clinical research, drug development, drug development research, drug efficacy research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Hosting an online network service in the nature of an website that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Clinical diagnostic and consultation services for research purposes in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Computer services, namely, cloud hosting provider services and onsite provider services in the nature of technical support services, namely, installation, administration, and troubleshooting of problems for computer software for storing, analyzing and sharing information in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Providing an online network service in the nature of an website that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, medical diagnostics, clinical diagnostics, medical research, diagnostics, clinical research, drug development, drug development research, medical laboratory research, life sciences, biology, microbiology, immunology, metagenomics, genetic testing, genetics, oncology, dermatology, and personalized medicine; Database design and development; RNA analysis services for scientific research purposes involving the identification and treatment of disease; Medical research services
Owner
- Mindera Corporation, Vista, CA, US
Prosecution history
- 31 Jan 2026 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 21 Aug 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 21 Aug 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Aug 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 31 Jul 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 29 Jan 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 02 May 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 02 May 2024 — LETTER OF SUSPENSION E-MAILED
- 02 May 2024 — SUSPENSION LETTER WRITTEN
- 15 Apr 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 15 Apr 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 15 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 16 Jan 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 16 Jan 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 17 Oct 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED